Review of Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells

Pre-publication Review of

Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells

Reviewed On September 26, 2022

Verified

Submitted to

Reviewed by

Actions

Reviewed on September 26, 2022

Source

References

M., F. M., Kazem, M., S., N. M., O., N. A., H., H. R., Ismail, S., M., K. S. 2022. Rational Design, Synthesis and Biological Evaluation of Novel Pyrazoline-Based Antiproliferative Agents in MCF-7 Cancer Cells. Pharmaceuticals.